Table of Content

1. Executive Summary


2. Introduction

2.1 Overview of Rosacea

2.1.1 Symptoms of Rosacea
2.1.2 Causes of Rosacea
2.1.3 Types of Rosacea
2.1.4 Treatment of Rosacea


3. The U.S. Market Analysis

3.1 The U.S. Dermatology Drugs Market Analysis

3.1.1 The U.S. Dermatology Drugs Market by Value
3.1.2 The U.S. Dermatology Drugs Market by Segments

3.2 The U.S. Rosacea Market Analysis

3.2.1 The U.S. Rosacea Market by Value
3.2.2 The U.S. Rosacea Market by Volume
3.2.3 The U.S. Rosacea Market by Number of Patients Seeking Treatment
3.2.4 The U.S. Rosacea Market by Segments
3.2.5 The U.S. Rosacea Market Top Brands by Value
3.2.6 The U.S. Rosacea Market Top Brands by Volume


4. Competitive Landscape

4.1 The U.S. Rosacea Drugs Competitive Landscape
4.2 The U.S. Rosacea Market Players Competitive Landscape


5. Company Profiles

5.1 Foamix Pharmaceuticals Ltd.
5.1.1 Business Overview
5.1.2 Financial Overview
5.1.3 Business Strategy

5.2 Sol-Gel Technologies Ltd
5.2.1 Business Overview
5.2.2 Financial Overview
5.2.3 Business Strategy

5.3 Galderma
5.3.1 Business Overview
5.3.2 Business Strategy

5.4 Allergan Plc
5.4.1 Business Overview
5.4.2 Financial Overview
5.4.3 Business Strategy



List of Figures



Figure 1: Types of Rosacea
Figure 2: The U.S. Dermatology Drugs Market by Value; 2014-2018 (US$ Billion)
Figure 3: The U.S. Dermatology Drugs Market by Value; 2019-2023E (US$ Billion)
Figure 4: The U.S. Dermatology Drugs Market by Segments; 2018
Figure 5: The U.S. Rosacea Market by Value; 2016-2018 (US$ Billion)
Figure 6: The U.S. Rosacea Market by Value; 2019-2023E (US$ Billion)
Figure 7: The U.S. Rosacea Market by Volume; 2017-2018 (Million)
Figure 8: The U.S. Rosacea Market by Volume; 2019-2023E (Million)
Figure 9: The U.S. Rosacea Market by Number of Patients Seeking Treatment; 2018-2023E (Million)
Figure 10: The U.S. Rosacea Market by Segments; 2017
Figure 11: Foamix Pharmaceuticals Ltd. Revenue; 2013-2017 (US$ Million)
Figure 12: Sol-Gel Technologies Ltd. Revenue; 2016-2017 (US$ Million)
Figure 13: Allergan Plc Revenue; 2013-2017 (US$ Billion)
Figure 14: Allergan Plc Revenue by Segments; 2017
Table 1: The U.S. Rosacea Market Top Brands by Value; 2017
Table 2: The U.S. Rosacea Market Top Brands by Volume; 2017
Table 3: The U.S. Rosacea Drugs Competitive Landscape
Table 4: The U.S. Rosacea Market Players Competitive Landscape
Table 5: Foamix Pharmaceuticals Product Candidate Pipeline
Table 6: Foamix Pharmaceuticals Ltd. Catalyst and Events Calendar
Table 7: Sol-Gel’s Clinical-Stage Pipeline
Table 8: Sol-Gel Catalyst Calendar